mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.2 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.2 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |